Irritable Bowel Syndrome with Constipation
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome with Constipation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years [Phase 3]
A Phase 3 pediatric trial assessing safety and efficacy of tenapanor for irritable bowel syndrome with constipation (IBS-C) in patients aged…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: MOWOOT Device Treatment for Adults With Chronic Constipation [NA]
The clinical trial update reports completion of a study evaluating the MOWOOT device for adults with chronic constipation and related condit…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation [Phase 4]
A Phase 4 study completed evaluating the effect of tenapanor on the gut metagenome and metabolome in patients with irritable bowel syndrome …
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C [Phase 3]
Phase 3 pediatric trial evaluating long-term safety of linaclotide for functional constipation or irritable bowel syndrome with constipation…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 2]
Phase 2 trial evaluating plecanatide in children aged 6 to under 18 with irritable bowel syndrome with constipation has completed and result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome [NA]
This is an ongoing clinical trial evaluating a nutraceutical composition for effects on signs and symptoms in adults with irritable bowel sy…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: The Effect of Inulin Supplementation in Individuals With IBS-C [NA]
A completed clinical trial evaluating the effect of inulin supplementation in individuals with Irritable Bowel Syndrome, including IBS with …
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) [Phase 3]
A Phase 3 pediatric trial evaluating the safety and efficacy of linaclotide in children aged 6 to 17 with functional constipation or irritab…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome [Phase 3]
Phase 3 study evaluating the efficacy and safety of ASP0456 for Irritable bowel syndrome with constipation has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: GOS to Reduce Symptom Severity in IBS [NA]
A completed clinical trial sponsored by Clasado evaluated galacto-oligosaccharide (GOS) for reducing symptom severity in irritable bowel syn…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome [Phase 2]
A Phase 2 clinical trial evaluating ASP0456 in constipation-predominant irritable bowel syndrome (IBS-C) has completed. The update reports t…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)
This is a completed post-marketing surveillance study evaluating the safety of Linaclotide tablets in patients with chronic constipation and…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Evaluate the Safety of Linaclotide in IBS-C Patients in China
A completed clinical trial assessing the safety of Linaclotide in patients with irritable bowel syndrome with constipation (IBS-C) in China.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) [Phase 2]
This trial update reports termination of the Phase 2 study of olorlinab for irritable bowel syndrome, including IBS with constipation and IB…
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 4]
Phase 4 trial update evaluating linaclotide's effect on abdominal girth in IBS-C; study terminated with results posted earlier.
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Effect of Tai Chi as Treatment for IBS-C [NA]
Completed clinical trial investigating Tai Chi as a treatment for Irritable Bowel Syndrome with Constipation; results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Efficacy and Safety of SYN-010 in IBS-C [Phase 2]
Phase 2 trial update for SYN-010 in irritable bowel syndrome with constipation (IBS-C) has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation [Phase 2]
Phase 2 clinical trial evaluating multiple oral doses of linaclotide in children aged 7-17 with irritable bowel syndrome with constipation; …
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 3]
Phase 3 trial of linaclotide 290 μg in irritable bowel syndrome with constipation has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: SAT vs Escitalopram for Rectal Hypersensitivity [Phase 2]
Phase 2 trial update comparing SAT to escitalopram for rectal hypersensitivity in IBS-C; study completed.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 2]
Phase 2 trial update for linaclotide in irritable bowel syndrome with constipation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation [NA]
Clinical trial update on CSP01 for chronic idiopathic constipation and irritable bowel syndrome with constipation has completed with results…
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) [Phase 3]
Phase 3 trial update for plecanatide in irritable bowel syndrome with constipation (IBS-C) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 3]
Phase 3 trial update for plecanatide in irritable bowel syndrome with constipation has completed, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation [Phase 3]
An open-label, long-term safety study evaluating linaclotide in patients with chronic constipation or irritable bowel syndrome with constipa…